Commercial Credit Report for Eurofarma Laboratorios SA

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Eurofarma Laboratorios SA is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

	Eurofarma Laboratorios SA
Ingahi
Phone: +55 1150908570p:+55 1150908570	ITAPEVI, 06.696-000 Brazil	Ticker: EUFA3EUFA3

Business Summary

Eurofarma Laboratorios SA is a Brazil-based pharmaceutical company engaged in the medicinal and botanical manufacturing. The Company provides health care services and focuses on producing, promoting, and marketing products and services. The Firm also operates in the wholesale of medicines, drugs, cosmetics, perfumery products and general merchandise with a predominance of food products. The Company operates in three main pharmaceutical branches, such as medical prescription (production of medicines prescribed by doctors) and non-prescription (production of medicines that do not have a prescription), generic (production of medicines with the same asset, but at lower prices), and hospital (commercialization of drugs and solutions in bulk). The Company operates in the Latin American market, being present in more than 20 countries in South and Central America, Caribbean, and Africa, with plants distributed in Latin America.

(Source: F-4)

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
Yes	Yes	-	-	-	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
6/30/2024	12/31/2023	Yes	-	-	-	-

Industries

SIC Code	Description
2834	Pharmaceutical preparations

General Information

Outstanding Shares:	987,568,073	(As of 6/30/2024)
Stock Exchange:	SAO

SITE MAP | ABOUT US | DIRECTORY | STOCK QUOTE: CRMZ | SIGN IN